We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Pre-Operative MRI Effective in Women with Dense Breasts

By HospiMedica International staff writers
Posted on 11 Nov 2020
Print article
Pre-operative MRI can catch more breast cancer lesions in women with dense breasts who receive an initial diagnosis via digital breast tomosynthesis (DBT), according to a new study.

Researchers at the University of Pennsylvania (Penn; Philadelphia, USA) conducted a retrospective study of 388 preoperative MRI exams for newly detected breast cancer identified either by digital mammography (DM) or DBT, in order to assess the role of MRI in assessment of tumor extent. MRI detection of occult disease was stratified by modality, breast density, and background parenchymal enhancement. A true-positive finding was defined as malignancy in the ipsilateral-breast at least two cm away from the index-lesion, or in the contralateral breast.

The results revealed 50 additional malignancies (12.9%), 37 of them ipsilateral and 13 contralateral. But while in DM there was no significant difference in the rate of MRI additional cancer detection in dense breasts, in those who underwent DBT, significantly more additional sites of malignancy were detected. In addition, in both DM and DBT cohorts, higher background parenchymal enhancement was associated with higher false-positive rates, but no significant difference was found in true-positive exams. The study was published on October 13, 2020, in Clinical Imaging.

“We found a trend of increasing detection by MRI of additional sites of malignancies in patients with dense breasts compared to those with non-dense breasts, irrespective of initial imaging modality,” said senior author Elizabeth McDonald, MD, PhD. “These findings suggest that in women imaged with DBT, MRI may have less value for determining extent of disease than in women with non-dense breasts. Women with dense breasts appear to benefit more from pre-operative MRI than non-dense women.”

Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.

Related Links:
University of Pennsylvania

Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Cardiograph
PageWriter TC10

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.